Toxoplasma gondii News and Research

RSS

How the gut microbiome contributes to schizophrenia

Researchers explore potential relationships between schizophrenia, the gut microbiome, the gut-brain axis, and short-chain fatty acids.

19 Oct 2023

'Guard mechanism' discovered for protein that attacks microbes in infected cells

Researchers have identified a 'guard mechanism' for a protein which attacks microbes in infected cells, opening the possibility of new treatments for Toxoplasma, Chlamydia, Tuberculosis and even cancer.

5 Oct 2023

The infection connection: investigating the impact on dementia risk, neuroimaging reveals

Researchers compared the association between neuroimaging markers of dementia and antibodies to common infection.

17 Jul 2023

Study reveals human population density and climate factors drive spread of Toxoplasma gondii through feline feces

A significant correlation between human population density, temperature variation, and the prevalence of Toxoplasma gondii shedding in domestic and wild cats

27 Jun 2023

Common infections in mid- and late-life can worsen cognitive performance

A new study from a team led by researchers at the Johns Hopkins Bloomberg School of Public Health found that signs of common infections in a sample of middle-aged and older adults were associated with poorer performance on a test of global cognitive function.

20 Apr 2023

On-site ultrasensitive monkeypox viral testing using CRISPR/Cas12a

In a new study posted to the medRxiv* preprint server, researchers in China developed an MPXV assay combining clustered regularly interspaced short palindromic repeats and CRISPR-associated protein (CRISPR/Cas) and recombinase-aided amplification (RAA) for the first time.

18 Oct 2022

Researchers explore the relationship between vitamin D levels and T. gondii infection

Announcing a new article publication for Zoonoses journal. Vitamin D deficiency is associated with high susceptibility to infections.

26 Aug 2022

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

Many doctors caution their pregnant patients to avoid cat feces; even the family pet's litter box is off-limits. Now, a group of researchers from Clemson University have discovered a promising therapy for those who suffer from toxoplasmosis, a disease caused by the microscopic protozoa Toxoplasma gondii.

11 May 2022

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

As part of World Malaria Day 2022, we interview Karine Le Roch PH.D., about her latest research into how novel antimalarial therapeutic strategies could be on the horizon, after identifying two proteins that are critical to the survival of the malaria parasite, Plasmodium falciparum.

25 Apr 2022

Study reveals a complexity to how the body "regulates the regulators" of the immune system

Checkpoint inhibitors have become important tools in the cancer-fighting arsenal. By blocking proteins that normally restrain the immune response, these drugs can help the immune system destroy cancer cells.

20 Apr 2022

Scientists discover mechanism that enables Listeria-infected cells to escape immune responses

Some "hypervirulent" strains of Listeria monocytogenes have a greater capacity to infect the central nervous system.

16 Mar 2022

Pathogens turn off mitochondrial defense by hijacking a normal cellular response to stress

Mitochondria are known as energy suppliers for our cells, but they also play an important role in the defense against pathogens. They can initiate immune responses, and deprive pathogens of the nutrients they need to grow.

17 Jan 2022

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

New research optimizes methods for the in-planta expression of the recombinant protein corresponding to the Receptor Binding Domain (RBD) subunit of the surface-exposed Spike glycoprotein of SARS-CoV-2.

15 Dec 2021

Deadly parasite could potentially be used to treat various types of cancers

Scientists have discovered that a deadly parasite, known to cause ill health in pregnant women and immunocompromised patients, could potentially be used to treat various types of tumors.

3 Nov 2021

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.

18 Sep 2021

Mother-to-baby SARS-CoV-2 transmission in pregnancy possible but rare, says study

A new meta-analysis, released on the medRxiv* preprint server, suggests that, though possible, the virus is rarely transmitted to the newborn in real life. A scientific brief from the World Health Organization (WHO) in February 2021 describes three mechanisms by which the virus might be transmitted from the mother to the fetus or newborn.

7 Jul 2021

Toxoplasma gondii News and Research

How the gut microbiome contributes to schizophrenia

'Guard mechanism' discovered for protein that attacks microbes in infected cells

The infection connection: investigating the impact on dementia risk, neuroimaging reveals

Study reveals human population density and climate factors drive spread of Toxoplasma gondii through feline feces

Common infections in mid- and late-life can worsen cognitive performance

On-site ultrasensitive monkeypox viral testing using CRISPR/Cas12a

Researchers explore the relationship between vitamin D levels and T. gondii infection

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

Study reveals a complexity to how the body "regulates the regulators" of the immune system

Scientists discover mechanism that enables Listeria-infected cells to escape immune responses

Pathogens turn off mitochondrial defense by hijacking a normal cellular response to stress

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

Deadly parasite could potentially be used to treat various types of cancers

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

Mother-to-baby SARS-CoV-2 transmission in pregnancy possible but rare, says study

Researchers identify key role of enzyme essential for invasion of the toxoplasmosis parasite

Brain organoid models reveal mechanisms linked to virus-induced microcephaly

Pilot study finds Bartonella infection in the blood of people with schizophrenia

Study suggests link between T. gondii infection and risk of aggressive brain cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News